Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine. (academic.oup.com)

Authors: Fong Y … Gilbert PB Journal: Clinical Infectious Diseases Published: 2026-04-30 DOI: https://doi.org/10.1093/cid/ciaf558